A study now shows that signaling downstream of TLR5 might have a role in the development of systemic lupus erythematosus (SLE). The TLR5 gene, which encodes the receptor for bacterial flagellin ...

“Statera’s TLR5 immunotherapy program strongly complements our work on non-invasive vagus nerve stimulation, positioning us to address immune and autonomic dysregulation-and associated ...

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced year end December 31, 2024 ...

The company announced that they had acquired worldwide exclusive license rights to a late-stage Toll-like Receptor 5 (TLR5) agonist for the treatment of acute radiation syndrome. The news sparked ...